Chemical Compound Review:
AC1NUNYN (2S)-2-[[(2S)-2-[[(2S)-2-[2- [[(2R)-2...
Synonyms:
LS-21621, Tyr-Ala-Gly-Phe-Leu-Arg, 2-Ala-6-Arg-Leu-enkephalin, Leu-enkephalin, Ala(2)-Arg(6)-, enkephalin, Ala(2)-Leu(5)-Arg(6)-, ...
- The anti-arrhythmic effect of D-Ala 2, Leu 5, Arg 6-enkephalin and its possible mechanism. Maslov, L.N., Lishmanov, Y.B. International journal of cardiology. (1993)
- Oxidative modification of plasma proteins during hypothermia and after dalargin administration. Klichkhanov, N.K., Ismailova, Z.G., Emirbekov, E.Z. Bull. Exp. Biol. Med. (2001)
- Misoprostol and dalargin for the inpatient treatment of duodenal ulcer in the USSR. Dajani, E.Z., Penin, V.A., Sokolov, L.K., Vahtangishvilli, R., Bogdanov, A., Afonskaya, N., Ivanishvilli, L., Zharova, Y., Efremova, I. Journal of the Association for Academic Minority Physicians : the official publication of the Association for Academic Minority Physicians. (1991)
- Chronotropic effect of D-Ala2,Leu5,Arg6-enkephalin (dalargin) is associated with activation of peripheral kappa-opioid receptors. Maslov, L.N., Barzakh, E.I., Platonov, A.A., Minin, S.M., Ovchinnikov, M.V. Bull. Exp. Biol. Med. (2005)
- Activity profiles of dalargin and its analogues in mu-, delta- and kappa-opioid receptor selective bioassays. Pencheva, N., Pospisek, J., Hauzerova, L., Barth, T., Milanov, P. Br. J. Pharmacol. (1999)
- Analysis and separation of enkephalin and dalargin analogues and fragments by capillary zone electrophoresis. Solínová, V., Kasicka, V., Barth, T., Hauzerová, L., Fanali, S. Journal of chromatography. A. (2005)
- Direct evidence that polysorbate-80-coated poly(butylcyanoacrylate) nanoparticles deliver drugs to the CNS via specific mechanisms requiring prior binding of drug to the nanoparticles. Kreuter, J., Ramge, P., Petrov, V., Hamm, S., Gelperina, S.E., Engelhardt, B., Alyautdin, R., von Briesen, H., Begley, D.J. Pharm. Res. (2003)
- Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles). Kreuter, J., Alyautdin, R.N., Kharkevich, D.A., Ivanov, A.A. Brain Res. (1995)
- Stimulatory effect of opioid peptides and naloxone on rat spinal cord cells in primary dissociated culture. Kozlova, M., Kalentchuk, V. Int. J. Dev. Neurosci. (1994)
- Effects of central opiate and serotoninergic structures on heart rhythm during acute myocardial ischemia. Prokop'eva, E.V., Pivovarov, Y.I. Bull. Exp. Biol. Med. (2001)
- Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier. Kreuter, J., Shamenkov, D., Petrov, V., Ramge, P., Cychutek, K., Koch-Brandt, C., Alyautdin, R. Journal of drug targeting. (2002)
- Body distribution of 3H-labelled dalargin bound to poly(butyl cyanoacrylate) nanoparticles after i.v. injections to mice. Schroeder, U., Schroeder, H., Sabel, B.A. Life Sci. (2000)
- Improved brain uptake and pharmacological activity of dalargin using a peptide-vector-mediated strategy. Rousselle, C., Clair, P., Smirnova, M., Kolesnikov, Y., Pasternak, G.W., Gac-Breton, S., Rees, A.R., Scherrmann, J.M., Temsamani, J. J. Pharmacol. Exp. Ther. (2003)
- Double-coated poly (butylcynanoacrylate) nanoparticulate delivery systems for brain targeting of dalargin via oral administration. Das, D., Lin, S. Journal of pharmaceutical sciences. (2005)
- Indirect evidence that drug brain targeting using polysorbate 80-coated polybutylcyanoacrylate nanoparticles is related to toxicity. Olivier, J.C., Fenart, L., Chauvet, R., Pariat, C., Cecchelli, R., Couet, W. Pharm. Res. (1999)